FS Bancorp Inc. has released its second-quarter results for 2025. The company reported a decrease in total noninterest income, which fell by $683,000 to $10.3 million for the six months ending June 30, 2025, compared to $11.0 million for the same period in 2024. This decline was mainly due to a $629,000 decrease in gain on sale of loans, a $464,000 decrease in service charges and fee income, and a net decrease of $368,000 related to no activity in gain on sales of MSRs and loss on sale of investment securities. However, these decreases were partially offset by a $755,000 increase in other noninterest income, attributed to sales of nonmarketable equity securities at a $312,000 gain, bank-owned life insurance proceeds of $195,000, and a $101,000 increase in brokered loans fees. In terms of segment performance, the Commercial and Consumer Banking segment reported net income of $7.4 million, while the Home Lending segment recorded net income of $351,000. These figures compare to the previous quarter's net income of $7.8 million and $242,000, respectively, and the second quarter of 2024's net income of $8.0 million and $1.0 million. The bank's regulatory capital ratios remain strong, with total risk-based capital at 14.1% and Tier 1 leverage capital at 11.2% as of June 30, 2025. These ratios indicate that FS Bancorp is considered "well capitalized" according to FDIC standards. There was no specific outlook or guidance provided in the report.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.